Clearance of amyloid β-peptide from brain: transport or metabolism?

Zlokovic, Berislav V., Yamada, Shinya, Holtzman, David, Ghiso, Jorge, Frangione, Blas·2000·Nature Medicine

Cited by (188)

Items 101–188 of 188

  1. Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats
    Mohamed, Loqman A., Qosa, Hisham, Kaddoumi, Amal · 2015 · ACS Chemical Neuroscience
  2. Interleukin-4 affects microglial autophagic flux
    Run-Hong Tang, Rui-Qun Qi, Hua-Yan Liu · 2019 · Neural Regeneration Research
  3. Method for measurement of the blood–brain barrier permeability in the perfused mouse brain: application to amyloid-β peptide in wild type and Alzheimer’s Tg2576 mice
    Barbra LaRue, Elizabeth Hogg, Abhay P. Sagare, Suzana S. Jovanovic, Lawrence M. Maness, Calvin R. Maurer, Rashid Deane, Berislav V. Zloković · 2004 · Journal of Neuroscience Methods
  4. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin
    Ibolya Edit Andras, Sung Yong Eum, Wen Huang, Yu Zhong, Bernhard Hennig, Michal J. Toborek · 2009 · Molecular and Cellular Neuroscience
  5. Monocytes and Alzheimer’s disease
    Yu Feng, Lei Li, Xiaohong Sun · 2011 · Neuroscience Bulletin
  6. Quercetin protects against the Aβ25–35-induced amnesic injury: Involvement of inactivation of RAGE-mediated pathway and conservation of the NVU
    Rui Liu, Tiantai Zhang, Dan Zhou, Xiaoyu Bai, Weiling Zhou, Chao Huang, Jun-ke Song, Fang-rui Meng, Caixia Wu, Lin Li et al. · 2012 · Neuropharmacology
  7. Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
    Mugdha Agarwal, Rizwan Alam, Mohd Kabir Haider, Md. Zubbair Malik, Dae-Kwang Kim · 2020 · Nanomaterials
  8. Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit
    Szilvia Veszelka, Andrea E. Tóth, Fruzsina R. Walter, Zsolt Datki, Emese Mózes, Lívia Fülöp, Zsolt Bozsó, Éva Hellinger, Mónika Vastag, Barbara Orsolits et al. · 2013 · Journal of Alzheimer s Disease
  9. Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?
    Shaoxun Wang, Paige N Mims, Richard J. Roman, Fan Fan · 2016 · PubMed
  10. Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
    Takaomi C. Saido · 2013 · Proceedings of the Japan Academy Series B
  11. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Henna Martiskainen, Annakaisa Haapasalo, Kaisa M. A. Kurkinen, Jussi Pihlajamäki, Hilkka S. Soininen, Mikko O. Hiltunen · 2013 · Expert Opinion on Therapeutic Targets
  12. The multi-faceted impact of methamphetamine on Alzheimer’s disease: From a triggering role to a possible therapeutic use
    Mayuri Shukla, Bruno Vincent · 2020 · Ageing Research Reviews
  13. Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment
    Sepideh Shokouhi, John W. Mckay, Suzanne L. Baker, Hakmook Kang, Aaron B. Brill, Harry E. Gwirtsman, William R. Riddle, Daniel O. Claassen, Baxter P. Rogers, Alzheimer’s Disease Neuroimaging Initiative · 2016 · Alzheimer s Research & Therapy
  14. Common Pesticide, Dichlorodiphenyltrichloroethane (DDT), Increases Amyloid-β Levels by Impairing the Function of ABCA1 and IDE: Implication for Alzheimer’s Disease
    Li, Gongbo, Kim, Chaeyoung, Kim, Jaekwang, Yoon, Hyejin, Zhou, Huadong, Kim, Jungsu · 2015 · Journal of Alzheimer's Disease
  15. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease
    Ling Zhang, R. Postina, Ying-Qun Wang · 2009 · Cellular and Molecular Life Sciences
  16. Recent Insights on Alzheimer’s Disease Originating from Yeast Models
    David Seynnaeve, Mara Del Vecchio, Gernot Fruhmann, Joke Verelst, Melody Cools, Jimmy Beckers, Daniel P. Mulvihill, Joris Winderickx, Vanessa Franssens · 2018 · International Journal of Molecular Sciences
  17. Sevoflurane alters the expression of receptors and enzymes involved in Aβ clearance in rats
    Y. Liu, M. Gao, Lang-Chuan Ma, Ling Zhang, N. Pan · 2013 · Acta Anaesthesiologica Scandinavica
  18. Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle
    Beatrice Hauss‐Wegrzyniak, Gary L. Wenk · 2002 · Neuroscience Letters
  19. Regulation of cholesterol efflux by amyloid β secretion
    Gillian A. Scullion, Jill H. Fowler, K. Karali, Robin Coltman, Ryan Green, Colin Smith, Karen Horsburgh · 2010 · Journal of Neuroscience Research
  20. Impairments in Brain-to-Blood Transport of Amyloid-β and Reabsorption of Cerebrospinal Fluid in an Animal Model of Alzheimer's Disease are Reversed by Antisense Directed Against Amyloid-β Protein Precursor
    W. Banks, V. B. Kumar, S. Farr, R. Nakaoke, S. Robinson, J. Morley · 2011 · Journal of Alzheimer's Disease
  21. Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration
    Ming‐Jen Hsu, Joen‐Rong Sheu, Chien‐Huang Lin, Ming‐Yi Shen, Chung Y. Hsu · 2009 · Biochimica et Biophysica Acta (BBA) - General Subjects
  22. Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems
    Sally Hunter, Carol Brayne · 2012 · Alzheimer s Research & Therapy
  23. Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty
    Kyung‐Hyun Cho, Hye‐Jeong Park, Suk‐Jeong Kim, Jae-Ryong Kim · 2019 · International Journal of Environmental Research and Public Health
  24. Secretory proteostasis of the retinal pigmented epithelium: Impairment links to age-related macular degeneration
    Luminita Paraoan, Umar Sharif, Emil Carlsson, Wasu Supharattanasitthi, Nur Musfirah Mahmud, Tengku Ain Kamalden, Paul Stephenson Hiscott, Malcolm Joseph Jackson, Ian Grierson · 2020 · Progress in Retinal and Eye Research
  25. Cerebrospinal fluid dynamics
    2021 · Croatian Medical Journal
  26. Biomarkers Related to Endothelial Dysfunction and Vascular Cognitive Impairment: A Systematic Review
    Rui Martins, Maria Clara Zanon Zotin, Guilherme Riccioppo Rodrigues, Octávio Marques Pontes‐Neto · 2020 · Dementia and Geriatric Cognitive Disorders
  27. Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease
    Paris, Daniel, Ganey, Nowel, Banasiak, Magdalena, Laporte, Vincent, Patel, Nikunj, Mullan, Myles, Murphy, Susan F., Yee, Gi-Taek, Bachmeier, Corbin, Ganey, Christopher et al. · 2010 · The Journal of Neuroscience
  28. Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin
    Tomoko Kurata, Kazunori Miyazaki, Miki Kozuki, Nobutoshi Morimoto, Yasuyuki Ohta, Yoshio Ikeda, Koji Abe · 2011 · Neuroscience
  29. Protection of the Blood-Brain Barrier by Pentosan Against Amyloid-β-Induced Toxicity
    Mária A. Deli, Szilvia Veszelka, Boglárka Csiszár, Andrea E. Tóth, Ágnes Kittel, Mária Csete, Áron Sipos, Anikó Szalai, Lívia Fülöp, Botond Penke et al. · 2010 · Journal of Alzheimer s Disease
  30. In Vitro Investigation of Amyloid-β Hepatobiliary Disposition in Sandwich-Cultured Primary Rat Hepatocytes
    Loqman A. Mohamed, Amal Kaddoumi · 2013 · Drug Metabolism and Disposition
  31. Amyloid-beta accumulation, neurogenesis, behavior, and the age of rats.
    Russell M. Church, Miles C. Miller, David M. Freestone, Catharine Chiu, Doreen P. Osgood, Jason T. Machan, Arthur A. Messier, Conrad E. Johanson, Gerald D. Silverberg · 2014 · Behavioral Neuroscience
  32. Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
    Kalarickal Vijayan Dileep, Remya Chandra · 2019 · Current Drug Targets
  33. Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP
    Gerald D. Silverberg, Miles C. Miller, Crissey L. Pascale, Ilias N Caralopoulos, Yüksel Ağca, Cansu Agca, Edward G. Stopa · 2015 · Fluids and Barriers of the CNS
  34. Effects of a behaviorally active antibody on the brain uptake and clearance of amyloid beta proteins
    William A. Banks, Patrizia Pagliari, Ryota Nakaoke, John Edward Morley · 2004 · Peptides
  35. Studying the Neurovascular Unit: An Improved Blood–Brain Barrier Model
    Christoph M. Zehendner, Heiko J. Luhmann, Christoph R.W. Kuhlmann · 2009 · Journal of Cerebral Blood Flow & Metabolism
  36. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation
    A. L. Schwarzman, Maria V. Tsiper, Luisa L. Gregori, Dmitry Goldgaber, Janusz Frackowiak, Bozena Mazur‐Kolecka, Anastasia E. Taraskina, С. Н. Пчелина, Michael Peter Vitek · 2005 · Amyloid
  37. Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease?
    Anna Hadjihambi · 2021 · Analytical Biochemistry
  38. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors
    Duc Quyen Chu, Helen M. Cox, Soraia K.P. Costa, Herbert Herzog, Susan Diana Brain · 2003 · British Journal of Pharmacology
  39. Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis
    Inès R. H. Ben-Nejma, A Keliris, Verdi Vanreusel, Peter Ponsaerts, Annemie Van der Linden, Georgios A. Keliris · 2023 · Alzheimer s Research & Therapy
  40. Angiotensin II type 1 receptor deficiency protects against the impairment of blood–brain barrier in a mouse model of traumatic brain injury
    Lijun Yang, Zeshang Chen, Xiangdong Wan, Minghao Liu, Jianliang Wu, Yan Chen, Gengshen Zhang, Zhenzeng Fan · 2021 · International Journal of Neuroscience
  41. Single Photon Emission Computed Tomography and Positron Emission Tomography Imaging of Multi-drug Resistant P-glycoprotein—Monitoring a Transport Activity Important in Cancer, Blood–Brain Barrier Function and Alzheimer's Disease
    David R Piwnica-Worms, Aparna Hemant Kesarwala, Andrea Pichler, Julie L. Prior, Vijay Sharma · 2006 · Neuroimaging Clinics of North America
  42. Analysis of Cerebral Small Vessel Changes in AD Model Mice
    Abu Zaffar Shibly, Abdullah Md. Sheikh, Makoto Michikawa, Shatera Tabassum, Abul Kalam Azad, Xiaojing Zhou, Yuchi Zhang, Shozo Yano, Atsushi Nagai · 2022 · Biomedicines
  43. Endogenous Secretory Receptor for Advanced Glycation End-Products Inhibits Amyloid-β1-42 Uptake into Mouse Brain
    Takahiro Sugihara, Seiichi Munesue, Yasuhiko Yamamoto, Shigeru Sakurai, Nasima Akhter, Yoji Kitamura, Kazuhiro Shiba, Takuo Watanabe, Hideto Yonekura, Yasuhiko Hayashi et al. · 2012 · Journal of Alzheimer s Disease
  44. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer’s disease
    Walter J. Lukiw · 2006 · Expert Review of Neurotherapeutics
  45. Dysfunctional Characteristics of Circulating Angiogenic Cells in Alzheimer's Disease
    Soon‐Tae Lee, Kon Chu, Keun‐Hwa Jung, Daejong Jeon, Jae‐Jun Bahn, Jinhee Kim, Sang Kun Lee, Manho Kim, Jae‐Kyu Roh · 2010 · Journal of Alzheimer s Disease
  46. Effect of mouse strain as a background for Alzheimer’s disease models on the clearance of amyloid-β
    Hisham Qosa, Amal Kaddoumi · 2016 · Journal of Systems and Integrative Neuroscience
  47. 6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE)
    Kwang‐Hyun Choi, Kwang Su Lim, Juhee Shin, Seo Hee Kim, Young‐Ger Suh, Hyun‐Seok Hong, Hee Yeon Kim, Hee-Jin Ha, Young-Ho Kim, Jiyoun Lee et al. · 2015 · Bioorganic & Medicinal Chemistry
  48. Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases
    Annalisa Bruno, Cristina Milillo, Federico Anaclerio, Carlotta Buccolini, Anastasia Dell’Elice, Ilaria Angilletta, Marco Gatta, Patrizia Ballerini, Ivana Antonucci · 2024 · International Journal of Molecular Sciences
  49. Role of A β Transport and Clearance in the Pathogenesis and Treatment of Alzheimer’s Disease
    David M. Holtzman, Berislav V. Zloković · 2007 · Springer eBooks
  50. Overview of Preclinical and Clinical Trials of Nanoparticles for the Treatment of Brain Metastases
    Muhammad Izhar, Mohamed Fathi Al Gharyani, Ahed H. Kattaa, Juan J. Cardona, Ruchit P. Jain, Elaheh Shaghaghian, Yusuke S. Hori, Fred C. Lam, Deya Abu-Reesh, Sara Coleman Emrich et al. · 2025 · Pharmaceutics
  51. Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease
    Camilla Steen Jensen, Christian Sandøe Musaeus, Ruth Frikke‐Schmidt, Birgitte Bo Andersen, Nina Beyer, Hanne Gottrup, Peter Høgh, Karsten Vestergaard, Lene Wermuth, Kristian Steen Frederiksen et al. · 2020 · Frontiers in Neuroscience
  52. Reduced estimated glomerular filtration rate in Alzheimer's disease
    Enda Kerr, David Craig, Bernadette McGuinness, Kevin Dynan, Damian G. Fogarty, Janet A. Johnston, Anthony Peter Passmore · 2009 · International Journal of Geriatric Psychiatry
  53. Extracellular Chaperones and Amyloids
    Mark R. Wilson, Justin J. Yerbury, Stephen Poon · 2008 · Springer eBooks
  54. Serum-Derived Immunoglobulins Neutralize Adverse Effects of Amyloid-β Peptide on the Integrity of a Blood-Brain Barrier In Vitro Model
    Verena Poetsch, Winfried Neuhaus, Christian R. Noe · 2010 · Journal of Alzheimer s Disease
  55. Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems
    Tian, Chunhui, Ao, Zheng, Cerneckis, Jonas, Cai, Hongwei, Chen, Lei, Niu, Hengyao, Takayama, Kazuo, Kim, Jungsu, Shi, Yanhong, Gu, Mingxia et al. · 2025 · Science Advances
  56. Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism
    Jiaying Hu, Leyan Zheng, Ziyu Guan, Kexin Zhong, Fankai Huang, Qiankai Huang, Jing Yang, Weiyun Li, Shanshan Li · 2023 · Brain Research Bulletin
  57. Modeling Effect of a γ-Secretase Inhibitor on Amyloid-β Dynamics Reveals Significant Role of an Amyloid Clearance Mechanism
    Raibatak Das, Robert B. Nachbar, Leah Edelstein-keshet A, Jeffrey S. Saltzman, Matthew C. Wiener, Ansuman Bagchi, James A. Bailey, Daniel Coombs, Adam J. Simon, Richard J Hargreaves et al. · 2010 · Bulletin of Mathematical Biology
  58. Targeted Chemotherapy in Drug-Resistant Tumors, Noninvasive Imaging of P-Glycoprotein-Mediated Functional Transport in Cancer, and Emerging Role of Pgp in Neurodegenerative Diseases
    Jothilingam Sivapackiam, Seth T. Gammon, Scott E. Harpstrite, Vijay Sharma · 2009 · Methods in molecular biology
  59. Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β‐amyloid peptide accumulation in mice
    Hao Peng, Paola Bukuroshi, Matthew R. Durk, Paul V. Grootendorst, Xiaoyu Yan, Sophie R. Pan, Inés A.M. de Lannoy, K. Sandy Pang · 2021 · Biopharmaceutics & Drug Disposition
  60. Human Amyloid-β40 Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo
    H. B. Peng, K. Noh, Sophie R. Pan, V. Saldivia, Sylvia Serson, Anja Toscan, I. D. de Lannoy, K. Pang · 2020 · Drug Metabolism And Disposition
  61. Uncovering the System Vulnerability and Criticality of Human Brain Under Dynamical Neuropathological Events in Alzheimer’s Disease
    Jingwen Zhang, Qing Liu, Haorui Zhang, Michelle Dai, Qianqian Song, Defu Yang, Guorong Wu A, Minghan Chen · 2023 · Journal of Alzheimer s Disease
  62. Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-β
    Dexi Bi, Boying Gao, Yanan Shen, Zhibo Dai, Shichun Yang, Ligang Wang · 2025 · Brain Research
  63. A mathematical model on Aβ blood–brain transport: Simulations of plaques’ formation in Alzheimer’s disease
    Eleonora Ficiarà, Ilaria Stura, Caterina Guiot, Ezio Venturino · 2023 · Medical Hypotheses
  64. Modulating Role of TTR in Aβ Toxicity, from Health to Disease
    Isabel Cardoso, Luís Miguel Santos, Mobina Alemi · 2016 · InTech eBooks
  65. Measuring Amyloid‐β Peptide Concentrations in Murine Brain with Improved ELISA Assay
    Hao Peng, Inés A.M. de Lannoy, K. Sandy Pang · 2021 · Current Protocols
  66. Differences in the amyloid-β-induced inflammatory response in microglia from C57BL/6 and A/J strains of mice
    Sherri Dudal, Céline Morissette, Diane Lacombe, Patrick Tremblay, Francine Gervais · 2004 · Journal of Neuroimmunology
  67. Integrating Data for Modeling Biological Complexity
    Sally Hunter, Carol Brayne · 2013 · Springer eBooks
  68. Disease Influence on BBB Transport in Neurodegenerative Disorders
    Elizabeth C. M. de Lange · 2013 · AAPS advances in the pharmaceutical sciences series
  69. Apolipoproteins in Different Amyloidoses
    Marcin Sadowski, Thomas Wısnıewskı · 2007 · Springer eBooks
  70. Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human brain organoid microphysiological systems
    Chunhui Tian, Zheng Ao, Jonas Cerneckis, Hongwei Cai, Lei Chen, Henyao Niu, Kazuo Takayama, Jungsu Kim, Yanhong Shi, Mingxia Gu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Visualization of Cerebrospinal Fluid Dynamics in Normal and Spinal Pathophysiological Conditions Using Time Spatial Spin Labeling Inversion Pulse-MRI
    Shinya Yamada · 2017 · Spinal Surgery
  72. Cerebral Amyloid Deposition With 18F ‐Florbetapir PET Mediates Retinal Vascular Density and Cognitive Impairment in Alzheimer's Disease
    Zhigeng Chen, Hai‐Long He, Zhongyuan Qi, Sheng Bi, Hongwei Yang, Xuanyu Chen, Tianze Xu, Zi‐Bing Jin, Shaozhen Yan, Jie Lu · 2025 · Human Brain Mapping
  73. Co-Morbid Disease as Risk Factors Associated with Alzheimer’s Disease- An Overview
    Anubhav Tyagi, Nikhila Shekhar, Sakshi Tyagi · 2025 · Current Behavioral Neuroscience Reports
  74. Primary cilia–extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential
    Vishal Singh Guleria, Charisse N. Winston · 2026 · Alzheimer s & Dementia
  75. Leptin, Insulin and Blood-Brain Barrier Relations in Obesity
    W. Banks, N. Nonaka, S. Shioda, R. Nakaoke, J. Morley · 2005 · Elsevier eBooks
  76. Cholesterol, β-amyloid, and Alzheimer's disease
    Miguel A. Pappolla, Suzana S. Petanceska, Lawrence M. Refolo, Nicolas Guillermo Bazan · 2003 · Advances in cell aging and gerontology
  77. A Conclusive Review on Amyloid Beta Peptide Induced Cerebrovascular Degeneration and the Mechanism in Mitochondria
    Jayalal L.P. Merlin · 2013 · Journal of the Chosun Natural Science
  78. Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
    Donna Darlington · 2014 · Digital Commons - University of South Florida (University of South Florida)
  79. Diseases Mediated by the BBB
    William A. Banks · 2013 · Elsevier eBooks
  80. The role of NPxY domains in LRP1 receptor maturation and function
    Thorsten Pflanzner · 2011 · Gutenberg Open Science
  81. Diseases Mediated by the BBB: From Alzheimer's to Obesity
    William A. Banks · 2006 · Elsevier eBooks
  82. Dynamics of brain-fluid circulation are altered in the mature-onset Tet-off APP mouse model of amyloidosis
    Inès R. H. Ben-Nejma, A Keliris, Verdi Vanreusel, Peter Ponsaerts, Annemie Van der Linden, Georgios A. Keliris · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Disease Influence on BBB Transport in Neurodegeneration
    Elizabeth C. M. de Lange · 2022 · AAPS advances in the pharmaceutical sciences series
  84. Additional file 2 of Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance
    Weixi Feng, Yanli Zhang, Ze Wang, Hanrong Xu, Ting Wu, Charles Marshall, Junying Gao, Ming Xiao · 2020 · Figshare
  85. Additional file 1 of Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance
    Feng, Weixi, Zhang, Yanli, Ze Wang, Xu, Hanrong, Wu, Ting, Charles Marshall, Gao, Junying, Xiao, Ming · 2020 · Figshare
  86. Additional file 1 of Altered dynamics of glymphatic flow in a mature-onset Tet-off APP mouse model of amyloidosis
    Inès R. H. Ben-Nejma, A Keliris, Verdi Vanreusel, Peter Ponsaerts, Annemie Van der Linden, Georgios A. Keliris · 2023 · Figshare
  87. Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie
    Audrey Vautheny · 2019 · theses.fr (ABES)
  88. Modeling the control on the formation and dissolution of amyloid plaques in Alzheimer’s disease
    Francesca Acotto, Iulia Martina Bulai, Francesca Gladiali · 2026 · Communications in Nonlinear Science and Numerical Simulation